Hepatectomy After Conversion Therapy with Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitors and Anti-PD-1 Antibodies for Initially Unresectable Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma · 2023-10 · Volume 10 · 1709-1721
DOI: 10.2147/jhc.s432062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2023-10. Verfasst von Bingran Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatic Surgery, Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatic Surgery, Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
ORCID-Profile: Yongfa Zhang
Zitieren
APA
Yu, B., Zhang, N., Feng, Y., Zhang, Y., Zhang, T., & Wang, L. (2023). Hepatectomy After Conversion Therapy with Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitors and Anti-PD-1 Antibodies for Initially Unresectable Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma, Volume 10, 1709-1721. https://doi.org/10.2147/jhc.s432062
Vancouver
Yu B, Zhang N, Feng Y, Zhang Y, Zhang T, Wang L. Hepatectomy After Conversion Therapy with Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitors and Anti-PD-1 Antibodies for Initially Unresectable Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 2023;Volume 10:1709-1721. doi:10.2147/jhc.s432062
BibTeX
@article{Yu2023,
author = {Yu, Bingran and Zhang, Ning and Feng, Yun and Zhang, Yongfa and Zhang, Ti and Wang, Lu},
title = {Hepatectomy After Conversion Therapy with Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitors and Anti-PD-1 Antibodies for Initially Unresectable Hepatocellular Carcinoma},
journal = {Journal of Hepatocellular Carcinoma},
year = {2023},
volume = {Volume 10},
pages = {1709--1721},
doi = {10.2147/jhc.s432062}
}
EUVIMED